Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy

Current treatment of glaucoma relies on administration of daily drops or eye surgery. A gene therapy approach to treat steroid-induced glaucoma would bring a resolution to millions of people worldwide that depend on glucocorticoid therapy for a myriad of inflammatory disorders. Previously, we had ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Borrás, Teresa, Buie, LaKisha K., Spiga, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860029/
https://www.ncbi.nlm.nih.gov/pubmed/26855269
http://dx.doi.org/10.1038/gt.2016.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860029/
https://www.ncbi.nlm.nih.gov/pubmed/26855269
http://dx.doi.org/10.1038/gt.2016.14

Ejemplares similares